分子细胞遗传学市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

分子细胞遗传学市场按产品(试剂盒和试剂、仪器、软件和服务)、技术、应用和地理划分

分子细胞遗传学市场快照

Molecular Cytogenetics Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

分子细胞遗传学涉及染色体生物学的各个方面,在疾病诊断和染色体异常方面有广泛的应用。癌症和遗传疾病患者的日益流行对分子细胞遗传学市场需求的增加产生了直接的影响。根据世界卫生组织 (WHO) 的数据,癌症是欧洲第二大死亡和发病原因,每年有超过 370 万新病例和 190 万人死亡,其中烟草和过度饮酒是主要原因。每天积累的基因数据与肿瘤的诊断和预后密切相关,从而拓宽了癌症细胞遗传学在各种实践中的应用范围。遗传疾病及其与脑部疾病的联系,例如唐氏综合症、爱德华兹综合症、Patau 综合征和 Turner 综合征是少数几种在分子细胞遗传学中有多种应用的突出疾病之一。因此,随着癌症和遗传疾病的日益流行,对分子细胞遗传学的需求预计将在预测年份显着增加。

报告范围

根据报告的范围,需要细胞遗传学方法来检测染色体不稳定性,这有助于识别大体基因组变异。分子细胞遗传学技术用于细化通过细胞遗传学分析检测到的变异,以识别细微的基因组变异。

By Products
Instruments
Kits & Reagents
Software & Services
By Technique
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Karyotyping
Other Techniques
By Application
Cancer
Genetic Disorders
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

癌症部分预计将在预测期内显示出更好的增长

根据应用,它分为癌症、遗传疾病和其他应用。分子细胞遗传学在癌症染色体异常的快速和精确表征中发挥了重要作用。肿瘤学涉及肿瘤和癌症的诊断和治疗。癌症是发病率和死亡率的主要原因之一。在两性中,肺癌、乳腺癌和结直肠癌是世界上最常见的癌症之一,仅肺癌就占确诊病例总数的 13% 以上。因此,随着癌症负担的增加,对诊断的需求也在增加,导致研究市场的高速增长。

Molecular Cytogenetics Market

北美有望主导分子细胞遗传学市场

由于更好的医疗基础设施、有效的政府政策、庞大的跨国公司基础以及人们的高度认识,分子细胞遗传学市场在北美地区占据主导地位。分子细胞遗传学测试包含在医疗保险的国家保险政策中。主要重点是医疗保险和医疗补助服务中心。此外,老年人口的增长,以及对用于检测各种慢性疾病的体外诊断测试的需求不断增加,预计将在预测期内推动市场。

Molecular Cytogenetics Market 2

竞争格局

进入分子细胞遗传学市场的全球参与者有 Abbott Laboratories、Agilent Technologies, Inc.、Bio-Rad Laboratories, Inc.、F.Hoffmann-La Roche Ltd.、Illumina, Inc.、Oxford Gene Technology、PerkinElmer Inc.、Quest Diagnostics 和赛默飞世尔科技。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Cancer and Genetic Disorders

      2. 4.2.2 Increasing Focus on Targeted Therapies for Cancer Treatment

      3. 4.2.3 Rise in Funding for Research and Clinical Diagnosis

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Treatment

      2. 4.3.2 Lack of Awareness about the Emerging Diagnostic Technologies in Cytogenetics

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Products

      1. 5.1.1 Instruments

      2. 5.1.2 Kits & Reagents

      3. 5.1.3 Software & Services

    2. 5.2 By Technique

      1. 5.2.1 Fluorescence in Situ Hybridization

      2. 5.2.2 Comparative Genomic Hybridization

      3. 5.2.3 Karyotyping

      4. 5.2.4 Other Techniques

    3. 5.3 By Application

      1. 5.3.1 Cancer

      2. 5.3.2 Genetic Disorders

      3. 5.3.3 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Agilent Technologies, Inc.

      3. 6.1.3 Bio-Rad Laboratories, Inc.

      4. 6.1.4 F.Hoffmann-La Roche Ltd.

      5. 6.1.5 Illumina, Inc.

      6. 6.1.6 Oxford Gene Technology

      7. 6.1.7 PerkinElmer, Inc.

      8. 6.1.8 Quest Diagnostics

      9. 6.1.9 Thermo Fisher Scientific

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Molecular Cytogenetics Market market is studied from 2018 - 2026.

The Molecular Cytogenetics Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F.Hoffmann-La Roche Ltd., PerkinElmer, Inc., Thermo Fisher Scientific are the major companies operating in Molecular Cytogenetics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!